Timothy P. Walbert - Mar 11, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Mar 11, 2022
Transactions value $
-$1,969,814
Form type
4
Date filed
3/11/2022, 04:17 PM
Previous filing
Mar 1, 2022
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $554K +25K +4.67% $22.14 561K Mar 11, 2022 Direct
transaction HZNP Ordinary Shares Sale -$1.85M -18.3K -3.27% $100.77 542K Mar 11, 2022 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$675K -6.66K -1.23% $101.38 536K Mar 11, 2022 Direct F1, F3
holding HZNP Ordinary Shares 108K Mar 11, 2022 See footnote F4
holding HZNP Ordinary Shares 100K Mar 11, 2022 See footnote F5
holding HZNP Ordinary Shares 40.9K Mar 11, 2022 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -25K -2.72% $0.00 893K Mar 11, 2022 Ordinary Shares 25K $22.14 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.18 to $101.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.19 to $101.72 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F5 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F6 The stock option is fully vested and exercisable.